Medicine information DIACOMIT 250mg capsules

Product code:
W51468002
Quantity:
60
Indicated for:
epilepsy
Route of administration:
oral
Substance:
stiripentol (antiepileptic)
ATC
N03AX17 — Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics
Stiripentol is an antiepileptic medication used as adjunctive therapy for the treatment of Dravet syndrome, a rare form of epilepsy. It works by enhancing the effects of other antiepileptic drugs, such as clobazam and valproate, and by reducing neuronal excitability.

The medication is taken orally, as directed by a doctor, usually two or three times daily. It is important for patients to adhere to the treatment regimen and avoid abrupt discontinuation.

Patients should be aware of potential side effects, such as drowsiness, nausea, or decreased appetite. It is important to inform the doctor of any unusual symptoms.

Common side effects include drowsiness, nausea, and decreased appetite. In rare cases, severe reactions such as neutropenia or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about DIACOMIT 250mg

Substance:
stiripentol
Date of latest medicines list:
01-10-2026
Product code:
W51468002
Strength:
250mg
Pharmaceutical form:
capsules
Quantity:
60
Product type:
Original
Price:
789.61 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
LABORATOIRES BIOCODEX - FRANTA
Holder:
BIOCODEX - FRANTA
Number:
367/2007/02
Shelf life:
3 years

Pharmaceutical forms available for stiripentol

Strengths available for stiripentol

  • 250mg
  • 500mg

Official documents

The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.

Added to database:
04/01/2010
Source record updated:
20/10/2025

Warnings:

Driving impairment

This medicine may affect your ability to drive or use machines.

Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Suicidal ideation / mental changes

Seek medical help if suicidal thoughts or major behavior changes occur.

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Reimbursement lists for DIACOMIT 250mg Biocodex

G11 (C1) - Epilepsy

Price
789.61 RON
Copayment
789.61 RON
Patient payment
0.00 RON